Court Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Arrow Catheter System Recall Issued Over Risk of Pulmonary Embolism and Death The manufacturer has received at least 83 complaints of the recalled Arrow Catheter Systems separating while inside a patient’s vein, resulting in more than a dozen injuries. June 27, 2023 Katherine McDaniel Add Your Comments Nearly 300,000 Arrow Endurance Extended Dwell Peripheral catheter systems have been recalled, due to a defect that may cause the catheters to separate and leak, resulting in a risk of serious and potentially life-threatening health consequences, including pulmonary embolism and death to patients. The U.S. Food and Drug Administration (FDA) announced the Arrow catheter recall on May 19, designating it as a Class I medical device recall and warning health care professionals that continued use of the devices have a high probability of resulting in serious injuries or death. Peripheral catheters are thin tubes inserted into a patient’s vein to provide health care professionals with short-term access to draw blood, monitor blood pressure, and administer fluids, blood transfusions, chemotherapy, and other medications. According to the recall notice, the catheters can separate while still inserted inside of a patient’s blood vessel, which can disrupt the exchange of potentially life-saving medication and cause leaks. In addition, the separation of catheter connections can also allow fragments of the catheter tube to enter the patient’s blood stream and migrate to other areas of the body. Officials warn that if catheter fragments enter a patient’s blood stream, the foreign objects can cause serious and potentially life-threatening consequences, including pulmonary embolism, blockage of the blood vessels, injuries to the blood vessel walls, insufficient blood flow, blood clots, heart attack, or death.  Arrow Catheter System Recall Approximately 262,016 Arrow Endurance Extended Dwell peripheral catheter systems are impacted by the recall, including units distributed from October 26, 2018 until May 10, 2023. To date, the manufacturer have received at least 83 complaints related to the defective catheter systems. While no deaths have been reported, at least 18 of the reported incidents resulted in injuries due to separation of the catheter connections. Teleflex and Arrow International have instructed medical provider customers to stop using the catheters immediately, and to quarantine any remaining inventory. For more information on the recall, customers are encouraged to contact Teleflex and Arrow International customer service by phone at 1-866-396-2111, fax at 1-855-419-8507, or email Recalls@teleflex.com. Adverse side effects, reactions, or quality issues experienced after using the medical devices should be reported to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using the online voluntary reporting form. Previous Arrow Medical Device Recall Problems Arrow issued at least two other Class I medical device recalls last year, over defects that posed siimilar health hazards for patients. The first was an Arrow MAC Venous Catheter Kit recall issued on December 16, 2022, after a defect was found in the housings of the Micro Clave Clear Connectors included in the kits, which caused inadequate connections between the top and bottom housings that could result in cross-lumen leakages. As a result of the insufficient housing connections, patients could have been at an increased risk to experience leakage of blood, fluids, or medication, which could have disrupted or delayed potentially life-saving treatment. In addition, officials warned of the potential for air or infection to enter the patient’s blood stream due to inadequate catheter connections, which also posed potentially life-threatening risks to patients. Less than a week later, an Arrow intra-aortic balloon pump recall was issued for more than 2,000 Arrow intra-aortic balloon pumps that are used to provide cardiac assistance to patients with acute coronary syndrome and heart failure complications. That recall was issued following at least 241 consumer complaints related to issues involving the heart pump’s battery unexpectedly failing or prematurely depleting, with at least 135 of the complaints resulting in failure of the pump. Port Catheter Lawsuits This new Arrow recall comes amid a growing number of port catheter lawsuits filed against Bard and other manufacturers, involving complications associated with the design of certain port-a-cath products implanted to provide long-term access to administer medications or fluid for patients, such as chemotherapy or dialysis. Bard Port Catheter Lawsuit Did you or a loved one receive a Bard Powerport? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Bard Port Catheter Lawsuit Did you or a loved one receive a Bard Powerport? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Lawsuits have alleged there are design defects with the Bard PowerPort and similar port catheters systems sold in recent years. The port catheters consist of an injection site where a needle is inserted, as well as a polyurethane catheter tube that carries the drug into the blood vessel. However, plaintiffs indicate that certain designs are prone to fracture or fail, causing infections, blood clots and other complications. Given common questions of fact and law raised in a growing number of Bard PowerPort lawsuits pending throughout the federal court system, a motion has been filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML), seeking to centralize and consolidate the claims before one U.S. District Judge A group of plaintiffs are calling for all lawsuits over Bard port catheter complications to be coordinated during discovery and pretrial proceedings, but the manufacturer has opposed the call for PowerPort lawsuit centralization. The U.S. JPML is expected to consider oral arguments on the motion next month. Tags: Arrow, Catheter, Catheter Recall, Pulmonary Embolism, Teleflex Find Out If You Qualify for Port Catheter Compensation More Bard PowerPort Lawsuit Stories More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts June 3, 2025 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL May 19, 2025 Court Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case May 6, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (Posted: today) Large numbers of women are using short-form complaints to file abbreviated hair relaxer cancer lawsuits directly with the MDL court. MORE ABOUT: HAIR RELAXER LAWSUITReplacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025) NEC Formula Lawsuit Set To Go Before Jury in Aug. 2025 (Posted: yesterday) Opening statements will begin on August 8, 2025, involving a NEC infant formula lawsuit brought by a Maryland family. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITEnfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (06/17/2025)Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025) Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 4 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Court Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case May 6, 2025
Hair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (Posted: today) Large numbers of women are using short-form complaints to file abbreviated hair relaxer cancer lawsuits directly with the MDL court. MORE ABOUT: HAIR RELAXER LAWSUITReplacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)
NEC Formula Lawsuit Set To Go Before Jury in Aug. 2025 (Posted: yesterday) Opening statements will begin on August 8, 2025, involving a NEC infant formula lawsuit brought by a Maryland family. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITEnfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (06/17/2025)Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 4 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)